Opzelura 1.5% cream Images
Generic Name: ruxolitinib
This medication has been identified as Opzelura 1.5% cream. It is supplied by Incyte Corporation.
Opzelura is used in the treatment of Vitiligo; Atopic Dermatitis and belongs to the drug class topical antineoplastics. Opzelura 1.5% cream is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Opzelura
- Generic Name
- ruxolitinib
- Strength
- 1.5% cream
- Availability
- Prescription only
- Drug Class
- Topical antineoplastics
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Incyte Corporation
- National Drug Code (NDC)
- 50881-0007
See also:
Eucrisa
Eucrisa (crisaborole) is used to treat mild to moderate eczema (atopic dermatitis) Includes Eucrisa ...
Adbry
Adbry is used to treat moderate-to-severe atopic dermatitis (eczema) in adults and children aged 12 ...
Cibinqo
Cibinqo (abrocitinib) tablets are used for the treatment of moderate to severe eczema (atopic ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
More about Opzelura (ruxolitinib topical)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (6)
- Drug images
- Side effects
- Dosage information
- FDA approval history
- Drug class: topical antineoplastics
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.